Product Images Losartan Potassium 100 Mg

This is a label of Losartan Potassium 100mg tablets produced by NuCare Pharmaceuticals, Inc. It contains information about product details such as the NDC number, lot number, and expiration date. It warns to keep out of reach of children and store at controlled temperature. Customers are advised to check the manufacturer's label for a full list of ingredients.*

This text provides data from a study comparing the effectiveness of Atenolol and Losartan Potassium in reducing the risk of a primary endpoint in patients. The adjusted risk reduction of Losartan Potassium compared to Atenolol is reported as 13%, with a p-value of 0.021. The study monitored patients over a period of 66 months, with data recorded at various monthly intervals from month 6 to month 66.*

This is a chart that shows the percentage of patients who experienced a fatal or non-fatal stroke over a period of 66 months. Two medications, Atenolol and Losartan potassium, are being compared. However, the chart does not provide enough information to evaluate the effectiveness of either medication.*

This appears to be a table showing the results of a study related to stroke rates in patients based on age, gender, race, and medical history with Losartan Potassium and Atenolol medications. The table displays the number of events, rate percentages and hazard ratios for each medication subgroup.*

This text presents statistical information about risk reduction and event occurrences in a certain population. The risk reduction is reported as 16.1% and the value of p is given as 0.022. The chart shows the percentage of patients with events in two categories, represented as 40% and 20%.*